STipe Therapeutics appoints Dr Natalie Sacks as Independent Board Member and Dr Richard Bethell as Chief Development Officer - Arix Bioscience

Close Navigation

About Strategy Team Portfolio Insights Media Contact

Overlay

STipe Therapeutics appoints Dr Natalie Sacks as Independent Board Member and Dr Richard Bethell as Chief Development Officer

16th April 2020

Portfolio

This post references, or is about STipe Therapeutics. Find out more by clicking below

Aarhus, Denmark

Useful Tools

Download, print or share this article

Print

Print Article Email

Email

Print

Share Article